A University of Cambridge medtech spinout
52north.healthLinkedInCambridge, UKBiotechFounded 2018
5 sources · checked 1 time, last 48d ago
Startupmag calls this a grant funding round, while the other reports describe an equity round that also includes an Innovate UK grant; the latter characterization wins.; not on the page it cites, so not applied: date
4 sources
Developing: it holds up against its sources so far, and firms up as more reporting lands.
| Round | Amount | Announced | Lead | Buzz |
|---|---|---|---|---|
| Funding round | $4.2M more than £7.5M financing total £3.2m | 2026-09-29 | Hargreave Hale AIM VCT, Macmillan Ventures | No recent discussion |
5 sources · checked 1 time, last 48d ago [ VERIFIED ] read against 4 of 5 sources Startupmag calls this a grant funding round, while the other reports describe an equity round that also includes an Innovate UK grant; the latter characterization wins.; not on the page it cites, so not applied: date | ||||
52North builds low-cost diagnostic devices and digital tools that help patients and clinicians make safer, faster decisions in urgent care, especially for chemotherapy-related complications.
Checked against 10 sources on Oct 1
| Growth [ HISTORY ]: An earlier round, from the company's own announcement, found while researching the company. Checked like any round, but not new, so it stays out of the daily feed and alerts; a date range shows it. | $6.0M €9.5M financing total £4,720,000 | 2024-12-03 | Cedars-Sinai Intellectual Property Co, KHP Ventures | No recent discussion |
4 sources [ DEVELOPING ] Developing: it holds up against its sources so far, and firms up as more reporting lands. read against 1 of 4 sources
[ BUILT WITH ]·[ SEARCH ]found by Firecrawl search·[ SCRAPE ]4 pages read: eu-startups.com, genomeweb.com, finsmes.com·[ JSON ]round read into a schema, with the sentence that states it·[ VERIFY ]correctedchecked against 1 of 4 sources·[ BRANDING ]logo and colour from the homepage·[ AGENT ]company research by the Firecrawl agent | ||||
| EARLIER ROUNDS FROM COMPANY RESEARCH · DEVELOPING | ||||
| Venture investment | £100,000 | 2023-02-06 | Macmillan Cancer Support | |
Also named as backers in company research: Crista Galli Ventures, King’s Health Partners MedTech Innovations, Meltwind, Milltrust Ventures, Parkwalk Advisors, Meridian Health Ventures, Innovate UK, SBRI Healthcare, National Institute for Health and Care Research (NIHR), Accelerated Access Collaborative, NATO DIANA